U.S. Healthtech Stock News

Earlier in January 2026, Duolingo announced that long-time board member and Audit Chair Gillian Munson will become Chief Financial Officer on February 23, 2026, succeeding outgoing CFO Matt Skaruppa, who will shift to an advisory role to support a smooth transition. The company paired this leadership change with preliminary fourth-quarter 2025 figures showing strong year-over-year growth in daily active users and bookings, even as management emphasized ongoing product investment over...

If you are trying to figure out whether GE Vernova's current share price really makes sense, you are in the right place. The stock is up 71.0% over the last year, even though it has seen a 5.0% decline over the past week, a 2.9% decline over the past month and a 4.0% decline year to date from its last close of US$652.09. Recent news coverage has focused on GE Vernova's position in the capital goods space and how investors are responding to its role in the wider energy transition. This...

If you are wondering whether RenaissanceRe Holdings is still good value at around US$270.10 per share, this breakdown is designed to help you make sense of the current price. The stock’s moves have been relatively muted recently, with a 0.7% decline over the last week, a 0.8% decline over the past month and year to date, and an 8.2% return over one year and 76.5% over five years. Recent attention on RenaissanceRe has centered on how the company is positioned within the insurance and...

Ichor Holdings, Ltd. ( NASDAQ:ICHR ) shares have had a really impressive month, gaining 47% after a shaky period...

Key Insights Given the large stake in the stock by institutions, NewtekOne's stock price might be vulnerable to their...

As the U.S. stock market grapples with fluctuating bank earnings and inflation data, major indices like the Dow Jones, S&P 500, and Nasdaq have experienced recent declines. Amidst this volatility, identifying undervalued stocks can be a strategic move for investors looking to capitalize on potential market inefficiencies and secure assets at a discount.

As the U.S. stock market navigates through a period marked by fluctuating bank earnings, inflation concerns, and record highs in precious metals, investors are keenly observing sectors that could offer potential growth amid these uncertainties. In such an environment, companies with high insider ownership often attract attention as they may indicate confidence from those who know the business best.

As major stock indexes in the United States face volatility due to recent bank earnings, inflation data, and fluctuating retail sales figures, investors are seeking alternative opportunities beyond traditional blue-chip stocks. Penny stocks, a term that might seem outdated but remains significant for many investors, often represent smaller or newer companies with potential for growth at lower price points. In this article, we explore three penny stocks that stand out for their financial...

As the U.S. market navigates through a period of fluctuating indices and economic indicators, small-cap stocks present unique opportunities amid broader market volatility. In this landscape, identifying promising companies requires a keen eye for innovation and resilience, particularly those that can thrive despite challenges such as inflationary pressures and shifting consumer trends.

In January 2026, PTC Therapeutics issued full-year 2026 guidance, projecting total product revenue of US$700 million to US$800 million, excluding Evrysdi royalty and collaboration revenue, while also reporting stronger-than-expected preliminary 2025 product and royalty results driven by Sephience. The company coupled its outlook with updates on regulatory and pipeline progress, including FDA alignment on a Phase 3 Huntington’s trial for votoplam and continued engagement on vatiquinone and...

Natural Resource Partners (NRP) recently set a new 52 week high at US$111.15 after releasing solid third quarter 2025 earnings. This has put fresh attention on how the partnership’s mineral and royalty profile is being valued. See our latest analysis for Natural Resource Partners. At the latest share price of US$114.20, NRP’s recent 1 month share price return of 9.42% and year to date share price return of 9.80% sit alongside a very large 5 year total shareholder return. This suggests...

Standex International (SXI) has quietly attracted fresh attention after recent share price gains, with the stock showing positive returns over the past month and over the past three months, prompting investors to reassess the diversified manufacturer. See our latest analysis for Standex International. At a latest share price of $241.82, Standex International has paired its recent short term gains with a 1 year total shareholder return of 33.08% and a 5 year total shareholder return of...

Illumina (ILMN) is back on investors’ screens after recent trading, with the share price closing at US$146.99. The move comes against a backdrop of mixed short term returns and longer term share price pressure. See our latest analysis for Illumina. The recent 1 day share price return of 0.99% and 30 day share price return of 8.99% sit alongside a 90 day share price return of 58.05%. However, the 5 year total shareholder return of 61.24% and 3 year total shareholder return of 26.73% highlight...

Tower Semiconductor (NasdaqGS:TSEM) shares are in focus after the company and LightIC Technologies announced a collaboration on silicon photonics for frequency modulated continuous wave LiDAR in automotive, robotics, and Physical AI applications. See our latest analysis for Tower Semiconductor. The LightIC tie up comes after a stretch of strong momentum, with Tower Semiconductor’s share price at US$124.78 and a 90 day share price return of 68.24%, while the 1 year total shareholder return...

In recent days, several brokerage firms have reiterated positive views on Ashland, with multiple analysts maintaining favorable ratings and expressing greater confidence in the company’s outlook. This broad alignment around an "Outperform" consensus signals that research houses are increasingly focusing on Ashland’s repositioned specialty chemicals profile and exposure to resilient end-markets. Against this backdrop of strengthening analyst consensus, we’ll examine how this renewed...

Brady (BRC) is back in focus after its latest quarterly results highlighted a mix of strengths and questions, with long term revenue and EPS growth contrasted with slower organic growth in its core business. See our latest analysis for Brady. Those mixed signals seem to be reflected in the market, with the 90 day share price return of 9.33% and 1 year total shareholder return of 14.44% pointing to momentum that is still constructive rather than fading. If Brady’s latest results have you...

DaVita recently launched its Community Health Experience initiative, partnering with organizations such as the American Diabetes Association and the YMCA to deliver no-cost health screenings and education to under-resourced communities across the US. This program highlights how DaVita is tying kidney care to earlier detection of related conditions like diabetes and hypertension, potentially strengthening its role in broader community health management. Next, we’ll explore how this expanded...

Sensata Technologies recently launched its STEV high-voltage contactor series for battery electric and plug-in hybrid vehicles, offering scalable, customizable switching solutions engineered for safety, efficiency, and compliance with stringent automotive standards. This product line extends Sensata’s electrification portfolio into critical EV power-protection hardware, positioning its contactors as core components across a wide range of global vehicle platforms. We’ll now examine how the...

Recent analyst reactions to Vital Farms (VITL) followed the company’s unexpected reduction in its 2025 revenue guidance, with several firms adjusting their views while still pointing to what they see as resilient earnings fundamentals. See our latest analysis for Vital Farms. Vital Farms’ share price has eased back recently, with a 30 day share price return of 10.82% and a 90 day share price return of a 22.16% decline, even though the year to date share price return is still 2.58%. The 1 year...

In January 2026, Royal Caribbean Group joined Miami-Dade leaders to break ground on a new US$345 million, LEED-targeted Cruise Terminal G at PortMiami, designed for up to 7,000 passengers and large Icon-class ships. The terminal’s dedicated-yet-flexible design, energy-efficient features, and integrated parking and intermodal facilities are intended to reinforce Miami’s role as a global cruise hub while enhancing Royal Caribbean’s guest experience infrastructure. We’ll now examine how this...

DXC Technology (DXC) shares are back in focus after the company was confirmed as a RISE with SAP Validated Partner, a move that sharpens its pitch in enterprise cloud modernization. See our latest analysis for DXC Technology. Despite the RISE with SAP validation and new kiosk rollout work, DXC’s 90 day share price return of 13.82% sits against a weaker 1 year total shareholder return of 25.04%. This suggests some recent momentum after a tougher stretch. If DXC’s cloud and SAP push has your...

Wintrust Financial (WTFC) is back on investors’ radars after its recent share moves, with the stock last closing at US$143.15 as returns have differed between the past week and the past three months. See our latest analysis for Wintrust Financial. Those recent share moves sit within a mixed picture, with an 11.79% 90 day share price return alongside a 0.34% year to date share price return and a 5 year total shareholder return of 125.79%. This suggests momentum has been building over the...

JBT Marel (JBTM) entered 2025 with a formal name change from John Bean Technologies Corporation, a shift that places its food processing and automation focus front and center for investors tracking the stock. See our latest analysis for JBT Marel. The name change comes as JBT Marel’s share price trades at $156.29, with a 90 day share price return of 14.29% and a 1 year total shareholder return of 28.51%, suggesting building momentum rather than short term noise. If you are looking for other...

T-Mobile US (TMUS) has drawn fresh investor attention after launching its limited time Better Value family plan. The plan targets multi line customers with premium 5G data, entertainment perks and international features at a lower entry price. See our latest analysis for T-Mobile US. The Better Value launch comes as T-Mobile US shares trade at US$189.67, with a 90 day share price return showing a decline of 16.32% and a 1 year total shareholder return showing a decline of 10.06%, while the 3...